Genetic Disease Detection

Single gene testing is used for patients that have a known gene mutation and can help identify those genetic diseases in each embryo before implantation.  Testable genetic diseasesinclude Cystic Fibrosis, Tay Sachs Disease, Fragile X Syndrome.   By identifying embryos with these gene abnormalities, we can avoid implanting them before pregnancy occurs.

Chromosome Screening

The most common error in embryos is called aneuploidy. This means there are too many or too few chromosomes.  Screening embryos with PGS prior to transfer helps to achieve higher implantation rates, fewer pregnancy losses and lowers the risk of having to consider pregnancy termination.

Gender Identification

Every family is different and only you can decide when your family is complete.  With gender testing, you can choose the gender of the embryos that will be transferred to your gestational carrier and balance the gender of your existing children.

Advantages of using PGD/PGS

  •  Optimize chances for a healthy baby
  • Higher implantation and pregnancy rates
  • Lower miscarriage rates
  • Detect known genetic diseases
  • Implant chromosomally normal embryos
  • Identify gender for family balancing
  • Success is uniform for young women and
    older women if blastocysts are tested.

Critical factors for PGD/PGS

  • Most advanced technologies
  • Precision techniques
  • Experience with a high volume of PGS cases
  • Ability to culture to blastocyst stage
  • Proficiency of embryo biopsy
  • Cryopreservation of biopsied embryos